Compare AIN & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIN | ANIP |
|---|---|---|
| Founded | 1895 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 1994 | 1999 |
| Metric | AIN | ANIP |
|---|---|---|
| Price | $62.71 | $78.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $60.25 | ★ $110.00 |
| AVG Volume (30 Days) | 255.4K | ★ 256.0K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | N/A | ★ 419.23 |
| EPS | 1.14 | ★ 2.32 |
| Revenue | ★ $1,054,132,000.00 | $206,547,000.00 |
| Revenue This Year | $1.20 | $21.01 |
| Revenue Next Year | N/A | $17.59 |
| P/E Ratio | ★ $53.75 | $64.55 |
| Revenue Growth | ★ 7.29 | 2.47 |
| 52 Week Low | $41.15 | $70.15 |
| 52 Week High | $77.00 | $99.50 |
| Indicator | AIN | ANIP |
|---|---|---|
| Relative Strength Index (RSI) | 25.15 | 56.20 |
| Support Level | $53.83 | $76.87 |
| Resistance Level | $64.04 | $83.45 |
| Average True Range (ATR) | 2.87 | 2.18 |
| MACD | -1.81 | 0.24 |
| Stochastic Oscillator | 14.00 | 91.45 |
Albany International Corp is a textiles and materials processing company specializing in engineered fabrics and composite components and assemblies for the paper, industrial manufacturing and aerospace industries. It operates through two segments: Machine Clothing, which produces custom-designed fabrics and high-speed process belts for paper, paperboard, tissue, towel and pulp, as well as engineered fabrics for other industrial applications, and contributes the majority of revenue; and Albany Engineered Composites, which provides engineered composite parts for the aerospace and defense industries. The company generates revenue from the United States, Switzerland, Brazil, China, Mexico, France and other areas.
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.